FDA approves expanded indication for cardiac resynchronization therapy
Medtronic announced today that the FDA approved an expanded indication for its cardiac resynchronization therapy with implantable cardioverter defibrillator devices.
Cardiac resynchronisation therapy can significantly delay the progression of heart failure, latest study results suggest.